Skip to content
Disclosery

CUE CUE BIOPHARMA INC

Follow

COM (common), issuer CIK 1645460

2 managers (2 13F filers) reported a position in CUE shares at 2026-03-31, 1,700 shares in all. 2 filers opened a position and 0 filers sold out during the quarter.

Managers
2
13F filers
2
New
2
Added
0
Reduced
0
Sold out
0
Shares held by filers
1,700

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Tidemark, LLC1,500$345<0.01%new13F-HRTimeline
Advisory Services Network, LLC200$46<0.01%new13F-HRTimeline

Events

  • STROME MARK E and 5 other reporting persons reported 644,916 CUE shares, 8.5% of the class, as of 2026-07-14, in a 13G/A filed 2026-10-08. 0001213900-26-107721

    Accepted , ingested